Navigation Links
Sentry BioPharma Services Invests in Global Clinical Supply Services with -45C Freezer Expansion
Date:6/18/2012

INDIANAPOLIS, June 18, 2012 /PRNewswire/ -- Sentry BioPharma Services, a provider of global biopharmaceutical cGMP storage, supply chain management, prescription drug distribution and clinical packaging services, announced today the addition of a -45C environmental room to its cGMP facility in order to accommodate clients in need of clinical trial depot services and bulk cGMP storage. The expansion increases Sentry's capacity to warehouse and distribute temperature-sensitive pharmaceutical products including APIs, intermediates, clinical trial materials and commercial drug products.

(Logo: http://photos.prnewswire.com/prnh/20111018/DE87636LOGO )

Tim J. Mitchell, Sentry's president, notes, "The highly customized -45C freezer enhances Sentry's ability to serve global biopharmaceutical clients' clinical sites through a single depot location centrally located in North America. Recently, a large, publicly held biotechnology company selected Sentry based upon our proven track record of success, our robust quality management system, pristine regulatory compliance record and expertise as the premier provider of clinical supply depot services.  Further, Sentry identified a strong need within its European client base for clinical trial depot and API management services at this crucial temperature setting."  Mitchell continues, "By further building Sentry's risk management approach to the specialized handling of temperature-sensitive biopharmaceutical products, we are better able to assist our clinical trial clients in devising and implementing custom secondary labeling, packaging configurations and depot service solutions at Sentry's headquarters. This investment strengthens Sentry's position as a leader in the biopharmaceutical industry and contributes to new market expansion."

"Sentry will complete validation of the -45C freezer next month," says Dwayne Marcum, Sentry's chief operations officer.  Marcum adds, "Upon completion, the 1,200 square foot chamber will complement Sentry's existing ambient (15C to 25C); refrigerated (2C to 8C); frozen (-15C to -25C) and ultra low (-70C to -90C) environments.  The -45C environmental room is unique in that it was specially designed and built to continuously operate with triple redundancy, using state-of-the art refrigeration, temperature monitoring and controlling systems to provide optimal product safety and efficacy."

Since incorporating in 2005, Sentry has always embraced an innovative approach to solving technical challenges by offering tailored, high-quality services among the most stringent international regulations.  Sentry's on-demand services continue to reliably offer pharmaceutical and biotechnology companies with superior service, immediate regulatory compliance, speed to market and a high probability for a successful project outcome.

About Sentry BioPharma Services
Sentry BioPharma Services maintains cGMP temperature-controlled storage for vaccines and other biopharmaceutical product, controlled substances III – V, FDA labeling capability, drug distribution licenses and an active Foreign Trade Zone status to exclusively serve the global pharmaceutical, biotechnology and healthcare industries. Its facilities, infrastructure and services are specifically designed to meet the cGMP warehousing, labeling, packaging, cold chain logistics and contract service needs of pharmaceutical and biotech firms, health care providers and suppliers, contract research organizations (CROs), contract manufacturing organizations (CMOs), wholesalers, distributors and governmental entities.

Sentry's management team offers expertise in pharmaceutical cold chain storage and logistics, quality assurance, biopharmaceutical packaging and kitting development. Sentry also offers strategic solutions for global transportation and logistics, as well as end-to-end import and export management.

The company's validated processes and inventory tracking systems are FDA compliant, adhere to current Good Manufacturing Practices (cGMPs) and comply with the stringent standard operating procedures (SOPs) outlined in Sentry's Validation Master Plan. Sentry is VAWD® accredited, which ensures its storage, handling and distribution methods meet the recognized guidelines of the National Association of Boards of Pharmacy®. The company is privately held and strategically headquartered in Indianapolis, Indiana.

Media Contact:
April L. Lentz
Sentry BioPharma Services, Inc.
Phone: (866) 757-7400 ext. 107
Email: info@sentrybps.com  
Website: www.sentrybps.com 


'/>"/>
SOURCE Sentry BioPharma Services
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
2. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
3. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
4. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
5. S1 Biopharma Expands Focus to Include Male Sexual Health
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
8. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
9. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
10. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
11. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ... ... valued at US$ 7,167.6 Mn in 2015, and is expected ... CAGR of 5.6% from 2016 to 2024. ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt ... the first patients in Nashville , ... the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) ... designed to provide long-term reflux control by restoring normal ... affects nearly 65 million people in the ...
Breaking Medicine Technology:
(Date:4/29/2017)... ... 29, 2017 , ... Sterling Global Products is pleased to ... biodegradable, hanging flushable wipes dispensers and/or 42 count refill packs manufactured by this ... Texas, operates more than 350 stores throughout Texas and expanding into northern Mexico ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... April 28, 2017 , ... Beginning in 2017, Ridgecrest Herbals ... This begins with the popular ClearLungs Extra Strength formula. To ensure that the effectiveness ... in the following ways:, , Removal of the homeopathic element ...
(Date:4/28/2017)... ... April 28, 2017 , ... Date aired: April ... “Computers are everywhere and they’re here to stay,” said Sharon Kleyne on her ... Your Health on Voice America sponsored by Nature’s Tears® EyeMist®. So she was ...
(Date:4/28/2017)... ... 2017 , ... Children and adolescents who enter the foster ... in the general population. That’s because foster care is designed to protect children ... no fault of their own, youth who have experienced trauma often have difficulty ...
Breaking Medicine News(10 mins):